: STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+CD8 T cells to reject tumors without acute vascular toxicityCANCER RESEARCHIF16.62023-04-041PRE
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CART cells and clearance of bulky lymphomaSCIENCE TRANSLATIONAL MEDICINEIF14.62021-12-2251PRE
OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell anti-tumor efficacy and durability of responseCANCER RESEARCHIF16.62020-08-150PRE
Are OAR dose constraints for radical 3DCRT breast plans achievable? A one-year retrospective review.RADIOTHERAPY AND ONCOLOGYIF5.32019-04-010OAAI
Overall responses and survival in RCC on pegilodecakin with anti-PD-1EUROPEAN JOURNAL OF CANCERIF7.12019-03-010PREAI
Isolated Nodal Failure rates following curative intent radiotherapy in a modern cohortRADIOTHERAPY AND ONCOLOGYIF5.32018-04-010OAAI
Should all oropharyngeal squamous cell carcinomas be stratified by HPV p16 status?CLINICAL ONCOLOGYIF32017-06-010PREAI
Is there justification for age bias in HPV p16 testing for Oropharyngeal Squamous Cell Carcinoma?RADIOTHERAPY AND ONCOLOGYIF5.32017-03-010PREAI
PEG-rIL-10 treatment decreases FoxP3+ Tregs despite upregulation of intratumoral IDOONCOIMMUNOLOGYIF6.32016-06-2711OAAI
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's diseaseALZHEIMERS RESEARCH & THERAPYIF7.62010-12-2946OAAI
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironmentNATURE MEDICINEIF502010-09-05752PREAI
Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody InhibitorJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92010-07-01137OAAI